🇺🇸
United States · US · US:71860-101_34f9bf77-6d88-5782-e063-6294a90a6c54
TRYNGOLZA
Orange BookUNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerIonis Pharmaceuticals, Inc.
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1171860101011 SYRINGE, GLASS in 1 CARTON (71860-101-01) / .8 mL in 1 SYRINGE, GLASS
Annotations
UNII (FDA Substance ID)
NSY2BY6PSB
OLEZARSEN SODIUM
Orange Book
N218614
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "NSY2BY6PSB",
"rxcui": null,
"inchikey": null,
"display_name": "OLEZARSEN SODIUM",
"substance_type": "nucleicAcid",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"0f51aa8e-8475-8cf9-e063-6394a90a6848": {
"match": "brand_token",
"title": "TRYNGOLZA (OLEZARSEN SODIUM) INJECTION, SOLUTION [IONIS PHARMACEUTICALS, INC.]",
"spl_version": "6",
"published_date": "2025-05-14"
}
},
"productid": "71860-101_34f9bf77-6d88-5782-e063-6294a90a6c54",
"productndc": "71860-101",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "218614",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 80MG BASE/0.8ML (EQ 80MG BASE/0.8ML)",
"product_no": "001",
"approval_date": "Dec 19, 2024"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "OLEZARSEN SODIUM",
"proprietary_name": "TRYNGOLZA",
"active_ingred_unit": "mg/.8mL",
"application_number": "NDA218614",
"marketing_category": "NDA",
"nonproprietary_name": "olezarsen sodium",
"start_marketing_date": "20241219",
"active_numerator_strength": "80"
}Access this data programmatically
Query TRYNGOLZA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.